Calroy Health Sciences announced on October 27, 2026, that Selentra HP, a hormone-free supplement formulated for women from perimenopause through postmenopause, is now available through its website.

Key Takeaways

  • The daily serving is two capsules containing a postbiotic and a plant-leaf extract.
  • The research described by Calroy studied the ingredients separately, rather than the combined formula.
  • The product’s health statements have not been evaluated by the FDA.

What is in Selentra HP?

The supplement contains 500 milligrams of VMK223, a postbiotic derived from Bifidobacterium breve BB091109, and 600 milligrams of OsteoCaf, an extract of Dalbergia sissoo leaves. Calroy calls the two-ingredient blend FEM-936.

The recommended daily serving is one capsule in the morning and one in the evening. Calroy says the product is intended for women whether or not they use menopausal hormone therapy. The company advises women to speak with a healthcare provider before starting a new supplement.

What the ingredient research covers

Calroy cited two 12-week, randomized, placebo-controlled trials of VMK223 in women ages 40 to 55. One examined inflammatory markers and the other tracked skin measurements.

The company also cited a one-year, open-label study of OsteoCaf in postmenopausal women with low bone density who also took calcium and vitamin D. The studies used the individual ingredients at the same daily doses found in the product; they do not establish the effects of the combined formula.

Calroy said the supplement is produced under FDA-defined current good manufacturing practices. Its health statements have not been evaluated by the FDA, and the product is not intended to diagnose, treat, cure or prevent disease.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.